Search Results
Viewing: 371-380 of 404 | All
News
Study supports virotherapy as a potential treatment for brain tumors
A new study provides additional evidence of the efficacy of virotherapy for glioblastoma, the most deadly type of brain tumor. The research findings, published Feb. 1, 2022, in Clinical Cancer Research, indicate that an oncolytic herpes simplex virus, G207, appears to boost immune response and that this is associated with better overall survival for patients with glioblastoma.
Specialty
Intracranial Hypertension Clinic
The recognition of idiopathic intracranial hypertension in children has increased dramatically. We are leading the response to this trend with the development of a multidisciplinary clinic for the specialized diagnosis, treatment and ongoing care of these unique children.
Condition
Hemophilia Carrier
A hemophilia carrier is a female who has the gene that causes hemophilia A or hemophilia B deficiency.
Article
Meet Our Rehab Team
Members of the Rehabilitation team work closely to manage each aspect of patient care. Our goal is to enhance the patient’s functional abilities as well as provide support and education to the family.
Article
Spencer Lab Staff
Learn more about principal investigator John David Spencer, MD, and his dynamic team in the Spencer Lab.
Article
Physician Careers
Nationwide Children’s Hospital is always looking for excellent board certified and board eligible pediatric physicians to join our Medical Staff.
Article
Nahata Lab
Under the direction of principal investigator Leena Nahata, MD, the Nahata Lab focuses on improving reproductive and psychosocial outcomes in pediatric populations at risk for infertility. Learn more about the Nahata Lab and explore featured news and publications as well as information about current studies.
News
Childrens Oncology Drug Alliance (CODA) Formed to Facilitate Development of Treatments for Childhood Cancers
Researchers and children’s cancer advocates in Australia and the U.S. have formed a unique research and development alliance to facilitate development of treatments for children fighting neuroblastoma, the most common and fatal form of solid cancer affecting infants.
News
St. Baldrick's Foundation Funds $8.9 Million in Grants to Support the Most Promising Childhood Cancer Research
No hospital has a monopoly on good ideas. This is why the St. Baldrick's Foundation funds the most promising research — no matter where it takes place – from your backyard institution to other cutting edge research facilities treating childhood cancers around the globe. Since 2005, this philosophy has translated to more than 1,674 grants in 31 countries, totaling more than $322 million. Thanks to the tremendous efforts of volunteers, donors, partners and advocates across the country this past year, St. Baldrick's is proud to announce $8.9 million has been awarded in new grants.